FARALLON CAPITAL MANAGEMENT LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$19,395,000
-19.5%
500,0000.0%0.08%
-34.2%
Q1 2021$24,100,000
+363.3%
500,000
+400.0%
0.12%
+287.1%
Q4 2020$5,202,000
-82.2%
100,000
-93.3%
0.03%
-86.8%
Q2 2020$29,220,0001,500,0000.23%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders